United Kingdom

BioCryst Pharmaceuticals Inc (BCRX.OQ)

BCRX.OQ on NASDAQ Stock Exchange Global Select Market

8:01pm BST
Change (% chg)

$0.05 (+1.29%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Robert Ingram

75 2017 Chairman of the Board

Jon Stonehouse

57 2007 President, Chief Executive Officer, Director

Thomas Staab

50 2018 Chief Financial Officer, Senior Vice President, Chief Accounting Officer, Treasurer, IR Contact Officer

Yarlagadda Babu

65 2013 Senior Vice President - Drug Discovery

Lynne Powell

51 2015 Senior Vice President, Chief Commercial Officer